Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues.

Bibliographic Details
Title: Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues.
Authors: Vasconcelos, Carlos Franciney Moreira1,2 (AUTHOR) cfmvasconcelos@biof.ufrj.br, Ribas, Vinicius Toledo3 (AUTHOR) ribasvt@ufmg.br, Petrs-Silva, Hilda2 (AUTHOR) cfmvasconcelos@biof.ufrj.br
Source: Cells (2073-4409). Sep2023, Vol. 12 Issue 17, p2155. 19p.
Subject Terms: *RNA regulation, *NEURODEGENERATION, *ALZHEIMER'S disease, *HUNTINGTON disease, *PARKINSON'S disease, *AMYOTROPHIC lateral sclerosis, *MOTOR neuron diseases
Abstract: Advances in RNA-sequencing technologies have led to the identification of molecular biomarkers for several diseases, including neurodegenerative diseases, such as Alzheimer's, Parkinson's, Huntington's diseases and Amyotrophic Lateral Sclerosis. Despite the nature of glaucoma as a neurodegenerative disorder with several similarities with the other above-mentioned diseases, transcriptional data about this disease are still scarce. microRNAs are small molecules (~17–25 nucleotides) that have been found to be specifically expressed in the CNS as major components of the system regulating the development signatures of neurodegenerative diseases and the homeostasis of the brain. In this review, we sought to identify similarities between the functional mechanisms and the activated pathways of the most common neurodegenerative diseases, as well as to discuss how those mechanisms are regulated by miRNAs, using RNA-Seq as an approach to compare them. We also discuss therapeutically suitable applications for these disease hallmarks in clinical future studies. [ABSTRACT FROM AUTHOR]
Copyright of Cells (2073-4409) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:a9h&genre=article&issn=20734409&ISBN=&volume=12&issue=17&date=20230901&spage=2155&pages=2155-2173&title=Cells (2073-4409)&atitle=Shared%20Molecular%20Pathways%20in%20Glaucoma%20and%20Other%20Neurodegenerative%20Diseases%3A%20Insights%20from%20RNA-Seq%20Analysis%20and%20miRNA%20Regulation%20for%20Promising%20Therapeutic%20Avenues.&aulast=Vasconcelos%2C%20Carlos%20Franciney%20Moreira&id=DOI:10.3390/cells12172155
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: a9h
DbLabel: Academic Search Complete
An: 171855556
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Vasconcelos%2C+Carlos+Franciney+Moreira%22">Vasconcelos, Carlos Franciney Moreira</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> cfmvasconcelos@biof.ufrj.br</i><br /><searchLink fieldCode="AR" term="%22Ribas%2C+Vinicius+Toledo%22">Ribas, Vinicius Toledo</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> ribasvt@ufmg.br</i><br /><searchLink fieldCode="AR" term="%22Petrs-Silva%2C+Hilda%22">Petrs-Silva, Hilda</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> cfmvasconcelos@biof.ufrj.br</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cells+%282073-4409%29%22">Cells (2073-4409)</searchLink>. Sep2023, Vol. 12 Issue 17, p2155. 19p.
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: *<searchLink fieldCode="DE" term="%22RNA+regulation%22">RNA regulation</searchLink><br />*<searchLink fieldCode="DE" term="%22NEURODEGENERATION%22">NEURODEGENERATION</searchLink><br />*<searchLink fieldCode="DE" term="%22ALZHEIMER'S+disease%22">ALZHEIMER'S disease</searchLink><br />*<searchLink fieldCode="DE" term="%22HUNTINGTON+disease%22">HUNTINGTON disease</searchLink><br />*<searchLink fieldCode="DE" term="%22PARKINSON'S+disease%22">PARKINSON'S disease</searchLink><br />*<searchLink fieldCode="DE" term="%22AMYOTROPHIC+lateral+sclerosis%22">AMYOTROPHIC lateral sclerosis</searchLink><br />*<searchLink fieldCode="DE" term="%22MOTOR+neuron+diseases%22">MOTOR neuron diseases</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Advances in RNA-sequencing technologies have led to the identification of molecular biomarkers for several diseases, including neurodegenerative diseases, such as Alzheimer's, Parkinson's, Huntington's diseases and Amyotrophic Lateral Sclerosis. Despite the nature of glaucoma as a neurodegenerative disorder with several similarities with the other above-mentioned diseases, transcriptional data about this disease are still scarce. microRNAs are small molecules (~17–25 nucleotides) that have been found to be specifically expressed in the CNS as major components of the system regulating the development signatures of neurodegenerative diseases and the homeostasis of the brain. In this review, we sought to identify similarities between the functional mechanisms and the activated pathways of the most common neurodegenerative diseases, as well as to discuss how those mechanisms are regulated by miRNAs, using RNA-Seq as an approach to compare them. We also discuss therapeutically suitable applications for these disease hallmarks in clinical future studies. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Cells (2073-4409) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=a9h&AN=171855556
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cells12172155
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 19
        StartPage: 2155
    Subjects:
      – SubjectFull: RNA regulation
        Type: general
      – SubjectFull: NEURODEGENERATION
        Type: general
      – SubjectFull: ALZHEIMER'S disease
        Type: general
      – SubjectFull: HUNTINGTON disease
        Type: general
      – SubjectFull: PARKINSON'S disease
        Type: general
      – SubjectFull: AMYOTROPHIC lateral sclerosis
        Type: general
      – SubjectFull: MOTOR neuron diseases
        Type: general
    Titles:
      – TitleFull: Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vasconcelos, Carlos Franciney Moreira
      – PersonEntity:
          Name:
            NameFull: Ribas, Vinicius Toledo
      – PersonEntity:
          Name:
            NameFull: Petrs-Silva, Hilda
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 20734409
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 17
          Titles:
            – TitleFull: Cells (2073-4409)
              Type: main
ResultId 1